Showing results (171-180 of 549) with videos related to

Sort By:
Pageof 55
Oncology|January 1, 1996
Doxifluridine as palliative treatment in advanced gastric and pancreatic cancer patientsM Di Bartolomeo, E Bajetta, L Somma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVDV Bonfante, A Santoro, S Viviani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Formestane: an effective first-line endocrine treatment for advanced breast cancerN Zilembo, E Bajetta, C Noberasco, et al.
Cancer|February 15, 1986
A clinical study of the pineal gland activity in oncologic patientsP Lissoni, S Viviani, E Bajetta, et al.
Cell Biology and Toxicology|August 30, 2003
A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug developmentA Casartelli, M Bonato, P Cristofori, et al.
Seminars in Surgical Oncology|June 9, 2001
Diagnostic and prognostic tumor markers in the gastrointestinal tractE Seregni, L Ferrari, A Martinetti, et al.
The Journal of the American Association of Gynecologic Laparoscopists|May 9, 2001
Laparoscopic myomectomy: technique, complications, and ultrasound scan evaluationsS Landi, R Zaccoletti, L Ferrari, et al.
Pageof 55